Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
DiabetesType 1 Diabetes Mellitus
Interventions
DEVICE

Artificial Pancreas

"The system is composed of 3 main components:~1. Insulin infusion pump to infuse insulin. The pump model used in the study is t:slim, Tandem Diabetes Care.~2. Continuous glucose monitor (CGM) to continuously measure glucose levels in the interstitial fluid. Glucose levels will be measured by Dexcom G5® CGM.~3. MAP application (iMAP) that computes insulin infusion based on the glucose values. The application also alarms the user when glucose sensor values are approaching the hypoglycemic or hyperglycemic range. The iMAP runs on an android smartphone.~Every 10 minutes, iMAP retrieves the glucose values from the Dexcom G5 CGM via Bluetooth. The application computes an optimal insulin infusion rate based on i) the current glucose reading, ii) the glucose trend (i.e. how quickly the glucose level is rising or falling) and iii) the open-loop basal rates (study parameters). The insulin recommendations are then sent wirelessly via Bluetooth to the insulin pump."

Trial Locations (1)

Unknown

Camp Carowanis, Sainte-Agathe-des-Monts

All Listed Sponsors
lead

McGill University

OTHER

NCT03581968 - Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp | Biotech Hunter | Biotech Hunter